94386 ⎘
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems Benzopyrazoles; Hydrogenated benzopyrazoles
SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#2INHIBITORS OF NLRP3 INFLAMMASOME
#3HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS
#4C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#5NOVEL COMPOUNDS AS CK2 INHIBITORS
#6NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF
#7SULFONYL DERIVATIVES AS CCR6 INHIBITORS
#8SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
#9COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF
#10HETEROCYCLIC INHIBITORS OF MCT4
#11INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#12ATM KINASE INHIBITORS
#13COMPOSITIONS AND METHODS FOR TREATING CANCER
#14MODULATORS OF FSHR AND USES THEREOF
#15INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS
#16AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF
#17MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#18BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
#19Compounds
#20COMPOUNDS AND METHODS FOR INHIBITING FASCIN
#21PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
#22SOLID FORMS OF HETEROCYCLYLAMIDES AS IRAK4 INHIBITORS
#23Nitrogen-Containing Heterocyclic Compounds
#24HSD17B13 INHIBITORS AND USES THEREOF
#25SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#26INHIBITORS OF NLRP3 INFLAMMASOME
#27OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT
#28NOVEL AMINO ACID DERIVATIVES
#29NOVEL BENZENE DERIVATIVE AND IMMUNOSUPPRESSION-RELATED USE THEREOF
#30MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
#31TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND
#32COMPOUNDS USEFUL FOR REDUCING URIC ACID
#33BICYCLE COMPOUNDS AS TEAD INHIBITOR
#34CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME
#35AGENT FOR REDUCING VISCERAL FAT WEIGHT
#36ALKYLAMINE OR HETEROALKYLAMINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#37WORKFLOW FOR GENERATING COMPOUNDS WITH BIOLOGICAL ACTIVITY AGAINST A SPECIFIC BIOLOGICAL TARGET
#38ESTROGEN RECEPTOR BETA LIGANDS FOR THE PREVENTION AND TREATMENT OF MULTIPLE SCLEROSIS (MS) AND OTHER DEMYELINATING, INFLAMMATORY AND NEURODEGENERATIVE DISEASES
#39QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS
#40Compounds
#41INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE
#42TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#43SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS
#44NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#45ORAL COMPLEMENT FACTOR D INHIBITORS
#46ACRYLAMIDE COMPOUNDS
#47CARBOXAMIDE COMPOUNDS AS PGE2 RECEPTOR ANTAGONISTS
#48RAFT AGENT FOR PHOTO-CONTROLLED POLYMERIZATION, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
#49COMPOUNDS
#50MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#51NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS
#52MODULATORS OF THE INTEGRATED STRESS PATHWAY
#53BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS
#54SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS
#55METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
#56COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE
#57THERAPEUTIC COMPOUNDS AND METHODS OF USE
#58HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME
#59INDAZOLE COMPOUND AND PHARMACEUTICAL
#60C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#61COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#62PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#63NOVEL CAPSID ASSEMBLY INHIBITORS
#64MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#65SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#66COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#67HETEROCYCLIC ALDEHYDE TRAPPING COMPOUNDS AND USES THEREOF
#682-SUBSTITUTED BICYCLO[1.1.1]PENTANES
#69SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF
#70Covalent Inhibitors As Antiviral Agents
#71AGENT FOR REDUCING VISCERAL FAT WEIGHT
#72ARGININE METHYLTRANSFERASE INHIBITOR AND USE THEREOF
#73ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#74PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#75ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION
#76BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#77XANTHINE OXIDASE INHIBITOR
#78MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
#79Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#80INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCEL THERAPEUTICS
#81GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES
#82BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5
#83NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#84METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#85METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#86INHIBITORS OF KINASE NETWORKS AND USES THEREOF
#87Inhibitors of receptor interacting protein kinase I for the treatment of disease
#88Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase
#89TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE
#90SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
#91MODULATORS OF THE INTEGRATED STRESS PATHWAY
#92ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#93TEAD inhibitors and methods of uses thereof
#94SULFAMOYL BENZENE DERIVATIVES AND USES THEREOF
#95BET SUBFAMILY INHIBITORS AND METHODS USING SAME
#962-SUBSTITUTED BICYCLO[1.1.1]PENTANES
#97HSD17B13 INHIBITORS AND/OR DEGRADERS
#98Quaternary indazole glucocorticoid receptor antagonists
#99Bicyclic carboxamides and methods of use thereof
#100CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS
#101INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#102COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS
#103Compounds and methods for inhibiting fascin
#104INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF NLRP3 INFLAMMASOME
#105RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA
#106HISTONE DEACETYLASE INHIBITORS
#107Methods and intermediates for preparing therapeutic compounds
#108ARYL ETHER COMPOUNDS AS TEAD MODULATORS
#109HSD17B13 INHIBITORS AND USES THEREOF
#110SULFONAMIDE DERIVATIVES FOR PROTEIN DEGRADATION
#111Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same
#112NOVEL COMPOUNDS
#113Inhibitors of NLRP3 inflammasome
#114NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
#115INHIBITORS OF NLRP3 INFLAMMASOME
#116INHIBITORS OF NLRP3 INFLAMMASOME
#117INHIBITORS OF PU.1 FOR THE TREATMENT OF DISEASE
#118HSD17B13 INHIBITORS AND USES THEREOF
#119IMIDAZOQUINOLINE OR BENZOINDAZOLONE COMPOUND AND INTERMEDIATE FOR PREPARING SAME
#120Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
#121COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
#122HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER
#123BICYCLIC COMPOUNDS, COMPOSITIONS AND USE THEREOF
#124CSF1R KINASE INHIBITOR AND USE THEREOF
#125MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#126INHIBITORS OF NLRP3 INFLAMMASOME
#127Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
#128SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#129NAMPT MODULATORS
#130INDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR PARTIAL AGONISTS
#131NANOMATERIALS COMPRISING ESTER-LINKED ACETALS
#132COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#133HETEROCYCLIC COMPOUND
#134AGENT FOR REDUCING VISCERAL FAT WEIGHT
#135Carbamate compounds and methods of making and using same
#136NOVEL COMPOUNDS
#137Modulators of mas-related G-protein receptor X2 and related products and methods
#138INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#139PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN
#140Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor
#141SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#142METHIONINE METABOLIC PATHWAY INHIBITORS
#143PREPARATION METHOD FOR FUSED PYRAZOLE-TYPE COMPOUND
#144Substituted Heterocyclyl Derivatives as CDK Inhibitors
#145a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#146Heterocyclic compound
#147SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#148SULFONE DERIVATIVES
#149BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF
#150Substituted Alkynylene Compounds As Anticancer Agents
#151Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD
#152Pyrazolo compounds and methods of use thereof
#153Indazole Derivatives
#154COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF
#155Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#156COMPOUND AS A UBR BOX DOMAIN LIGAND
#157COMPOUND AS A UBR BOX DOMAIN LIGAND
#158AFMT ANALOGS AND THEIR USE IN METHODS OF TREATING PARKINSON'S DISEASE
#159BENZOPYRAZOLE COMPOUND
#160Inhibitors of HIF-2α and methods of use thereof
#161Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#162SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1
#163C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#164RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#165LIGHT EMITTING ELEMENT
#166Small molecule inhibitors of TEAD transcription factors
#167TRNA SYNTHETASE INHIBITORS
#168UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR
#169INDAZOLE HYDRAZIDE COMPOUND AND APPLICATION THEREOF
#170POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES
#171Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor
#172NUCLEAR RECEPTOR MODULATORS
#173INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES
#174CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS
#175Bicyclic compounds
#176γ-diketones as Wnt/β-catenin signaling pathway activators
#177Inhibitors of NLRP3 inflammasome
#178Methods and compounds for restoring mutant p53 function
#179Bicyclic carboxamides and methods of use thereof
#180Carboxylic acid aromatic amides
#181SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF
#182Quaternary indazole glucocorticoid receptor antagonists
#183INHIBITORS OF HIF-2ALPHA
#184Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#185AGENT FOR REDUCING VISCERAL FAT WEIGHT
#186Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#187NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#188Novel compounds and their use in therapy
#189NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF
#190COMPOUNDS
#191Heterocyclic compound
#192(AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#193SOLID STATE FORMS OF ARRY-797 AND PROCESS FOR PREPARATION THEREOF
#194COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS
#195Adaptive sheet caliper control system and apparatus and methods
#196MODULATORS OF THE INTEGRATED STRESS PATHWAY
#197Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
#198ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#199Modulators of Mas-related G-protein receptor X2 and related products and methods
#200SMARCA INHIBITORS AND USES THEREOF
#201Inhibitors of NLRP3 inflammasome
#202Aromatic sulfonamide derivatives
#203PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF
#204BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#205AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION
#206Toll-like receptor antagonist compounds and methods of use
#207INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS
#208Organic electroluminescent element and electronic device
#209COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
#210HETEROCYCLIC INHIBITORS OF MCT4
#211TERTIARY AMINE DERIVATIVES AND THEIR USES FOR TREATING A VIRAL INFECTION
#212Synthesis method for 1-methyl-1H-indazole-6-carboxylic acid
#213COMPOUND AS IRAK INHIBITOR
#214Novel compounds and methods of use treating fructose-related disorders or diseases
#215INHIBITORS OF SARM1
#216PROCESS FOR PREPARATION OF AXITINIB
#217INHIBITORS OF CD40-CD154 BINDING
#218DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST
#219SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#220Therapeutic indazoles
#221HYDRAZIDE COMPOUND AND KINASE INHIBITOR
#222BIARYL DERIVATIVE AS GPR120 AGONIST
#223INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#224SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#225Compositions and methods for the treatment of cancer
#226COMPOUNDS FOR TREATING RESPIRATORY DISEASE
#227Substituted Heterocyclyl Derivatives as CDK Inhibitors
#228Inhibitors of dihydroceramide desaturase for treating disease
#229PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION
#230BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS
#231Heterocyclic compound
#232Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
#233Oligo-benzamide analogs and their use in cancer treatment
#234Methods and intermediates for preparing therapeutic compounds
#235DUAL ACTING FKBP12 AND FKBP52 INHIBITORS
#236Bicyclic compounds and their use in the treatment of cancer
#237Substituted alkynylene compounds as anticancer agents
#238Inhibitors of kinase networks and uses thereof
#239Benzopyrazole compound used as RHO kinase inhibitor
#240Diacylglyceride O-acyltransferase 2 inhibitors
#241Activator of TREK (TWIK RElated Kchannels) channels
#242Compounds and methods for inhibiting fascin
#243Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#244FUSED DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS
#245PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#246COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES
#247Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same
#248SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#249Heterocyclic amide compounds having an RORvt inhibitory action
#250Compounds and uses thereof for the modulation of hemoglobin
#251Indole compounds and analogues thereof
#252ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS
#253SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#254Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#255Indomethacin analogs for the treatment of castrate-resistant prostate cancer
#256ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
#257Anti-fibrotic compounds
#258MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS
#259Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#260Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
#261COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
#262ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#263Compounds and Methods for Treating Bacterial Infections
#264NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
#265AGENT FOR REDUCING VISCERAL FAT WEIGHT
#266Carbamate compounds and methods of making and using same
#267COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
#268Heterocyclic compound
#269PRIMARY CARBOXAMIDES AS BTK INHIBITORS
#270Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use
#271Inhibitors of Rho associated coiled-coil containing protein kinase
#272METHOD FOR PREPARING A POLYFLUORINATED COMPOUND
#273COMPOSITIONS AND METHODS FOR TREATING CANCER
#274Opioid receptor modulators and products and methods related thereto
#275COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#276Analogs of fexaramine and methods of making and using
#277OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO
#278MODULATORS OF CELLULAR ADHESION
#279Compounds for treatment of cardiac arrhythmias and heart failure
#280Compositions for the treatment of pulmonary fibrosis
#281NUCLEAR RECEPTOR MODULATORS
#282Phenylamine compounds
#283C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#284Small-Molecule HIV-1 Capsid Protein Inhibitors and Methods Using Same
#285Preparation of pyrazolo[3,4-B]pyridines as antimalarials
#286Bicyclic heterocycles as FGFR inhibitors
#287Inhibitors of receptor interacting protein kinase I for the treatment of disease
#288PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER
#289Pesticidal compounds
#290P300/CBP hat inhibitors
#291Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
#292Workflow for generating compounds with biological activity against a specific biological target
#293TRNA synthetase inhibitors
#294Heterocyclic compounds as pesticides
#295E3 UBIQUITIN LIGASE AGONISTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE E3 UBIQUITIN LIGASE AGONISTS, RELATED METHODS OF USE
#296Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
#297Bicyclic carboxamides and methods of use thereof
#298BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
#299Heterocyclic compounds as pesticides
#300Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same